NOD1 deficiency ameliorates the progression of diabetic retinopathy by modulating bone marrow–retina crosstalk

Jingwen Qiu,Jing Wu,Wenwen Chen,Yu Ruan,Jingning Mao,Shue Li,Xuan Tang,Lei Zhao,Shengbing Li,Ke Li,Dongfang Liu,Yaqian Duan
DOI: https://doi.org/10.1186/s13287-024-03654-y
2024-02-11
Stem Cell Research & Therapy
Abstract:Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) plays a pivotal role in inducing metabolic inflammation in diabetes. Additionally, the NOD1 ligand disrupts the equilibrium of bone marrow-derived hematopoietic stem/progenitor cells, a process that has immense significance in the development of diabetic retinopathy (DR). We hypothesized that NOD1 depletion impedes the advancement of DR by resolving bone marrow dysfunction.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?